🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluated the safety and tolerability of low-dose linezolid (600...
Status
Completed
Location
King George V Hospital
Start Date
2009-04
Trial ID
NCT00664313
This is a Phase 2b/3, multi-center, two part study, designed to evaluate th...
Status
Completed
Location
CD02 Investigational site
Start Date
2015-10
Trial ID
NCT02483078
Treatments Being Tested
This is a 48-week study to compare TNX-355 plus OBT to placebo plus OBT in ...
Status
Unknown
Location
Body Positive
Start Date
2004-03
Trial ID
NCT00089700
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of raltegravir with o...
Status
Completed
Location
Multiple Locations
Start Date
2010-04
Trial ID
NCT01190124
Maraviroc (UK-427,857), a selective and reversible CCR5 co-receptor antagon...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2004-11
Trial ID
NCT00098748
This study will investigate the safety and efficacy of raltegravir as a the...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00293267
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of the CCR...
Status
Terminated
Location
GSK Investigational Site
Start Date
2005-07
Trial ID
NCT00297076
Treatments Being Tested
This study will investigate the safety and efficacy of different doses of a...
Status
Completed
Location
Multiple Locations
Start Date
2005-03
Trial ID
NCT00105157
Treatments Being Tested
The UNIVERSAL2 study is a research project designed to evaluate a newly dev...
Status
Withdrawn
Location
Centre Mère et Enfant de la Fondation Chantal Biya
Start Date
2025-02-01
Trial ID
NCT06139796
Treatments Being Tested
To assess the safety, tolerability and efficacy of Raltegravir (RAL) when c...
Status
Unknown
Location
Shanghai Public Health Clinical Center
Start Date
2010-09
Trial ID
NCT01201239
Treatments Being Tested